Gene · 54894
Papers2,200
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,200
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of Wnt Signaling Pathway Aberrations in Metastatic Prostate Cancer. | Mol Cancer Res | 2024 | 38912907 | PubTator, text mining | PubMed |
| Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS-altered, younger patients with colorectal cancer. | Oncologist | 2024 | 38886182 | PubTator, text mining | PubMed |
| Mesenchymal stem cell-derived apoptotic vesicles ameliorate impaired ovarian folliculogenesis in polycystic ovary syndrome and ovarian aging by targeting WNT signaling. | Theranostics | 2024 | 38855175 | PubTator, text mining | PubMed |
| Molecular profiling of pediatric and young adult colorectal cancer reveals a distinct genomic landscapes and potential therapeutic avenues. | Sci Rep | 2024 | 38849509 | PubTator, text mining | PubMed |
| Targeted protein degradation systems to enhance Wnt signaling. | Elife | 2024 | 38847394 | PubTator, text mining | PubMed |
| Design principles and therapeutic applications of novel synthetic WNT signaling agonists. | iScience | 2024 | 38832011 | PubTator, text mining | PubMed |
| Molecular characteristics of early-onset compared with late-onset colorectal cancer: a case controlled study. | Int J Surg | 2024 | 38742845 | PubTator, text mining | PubMed |
| Novel insights into tumorigenesis revealed by molecular analysis of Lynch syndrome cases with multiple colorectal tumors. | Front Oncol | 2024 | 38725616 | PubTator, text mining | PubMed |
| PH-binding motifs as a platform for drug design: Lessons from protease-activated receptors; PARs. | Oncoscience | 2024 | 38699225 | PubTator, text mining | PubMed |
| Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma. | Pathol Res Pract | 2024 | 38663178 | PubTator, text mining | PubMed |
| Lactobacillus rhamnosus GG Stimulates Dietary Tryptophan-Dependent Production of Barrier-Protecting Methylnicotinamide. | Cell Mol Gastroenterol Hepatol | 2024 | 38641207 | PubTator, text mining | PubMed |
| Gastric Carcinoma in Autoimmune Gastritis: A Histopathologic and Molecular Study. | Mod Pathol | 2024 | 38588886 | PubTator, text mining | PubMed |
| Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/β-catenin addiction in cancer. | Sci Adv | 2024 | 38569029 | PubTator, text mining | PubMed |
| NGS of brush cytology samples improves the detection of high-grade dysplasia and cholangiocarcinoma in patients with primary sclerosing cholangitis: A retrospective and prospective study. | Hepatol Commun | 2024 | 38551383 | PubTator, text mining | PubMed |
| Ring Finger 43 Hot-spot Frameshift Mutation G659V in Colorectal Cancer Patients: Report from a Tertiary Cancer Care Hospital in North India. | Int J Appl Basic Med Res | 2024 | 38504846 | PubTator, text mining | PubMed |
| Clonal analysis of metachronous double biliary tract cancers. | J Pathol | 2024 | 38482714 | PubTator, text mining | PubMed |
| Early adenocarcinoma mixed with a neuroendocrine carcinoma component arising in the gastroesophageal junction: A case report. | World J Gastrointest Oncol | 2024 | 38425401 | PubTator, text mining | PubMed |
| Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancer. | Hum Pathol | 2024 | 38423222 | PubTator, text mining | PubMed |
| Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer. | JCO Precis Oncol | 2024 | 38394466 | PubTator, text mining | PubMed |
| Neoplastic Progression in Macroscopic Precursor Lesions of the Pancreas. | Arch Pathol Lab Med | 2024 | 38386006 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54894/papers?page=8